Skip to content
Parakho

Poly Medicure Ltd

NSE POLYMEDBSE 531768polymedicure.com

Q1 FY27, unaudited

Revenue
₹525.38 Cr
Profit after tax
₹85.27 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations525.38+30.30%1,875.26
Other income33.41−19.87%120.08
Total income558.78+25.60%1,995.34
Employee benefit expense126.90+68.95%402.26
Finance costs6.50+120.38%18.29
Depreciation & amortisation36.25+55.88%115.52
Total expenses443.03+37.04%1,566.75
Profit before tax115.75−4.83%421.79
Tax expense32.03+7.26%106.74
Profit after tax85.27−8.39%320.73
Total comprehensive income85.23−7.75%367.22
Earnings per share
Earnings per share, basic₹8.49₹31.79
Earnings per share, diluted₹8.48₹31.75

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Poly Medicure reported standalone Q1 FY27 revenue of INR431 crores, up 12.3%, with consolidated revenue at INR525 crores, up 30.3% including contributions from the PendraCare and Citieffe acquisitions. Standalone EBITDA margin came in at 28%, above the guided range of 25% to 27%, while consolidated EBITDA margin was 24.1%, within the guided 23% to 25% range. Management outlined a five-year strategic plan called PolyMed 3.0 targeting a doubling of revenue by FY30, alongside commentary on Middle East logistics disruptions, renal segment pricing pressure from Chinese imports, and new leadership appointments.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 67 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Medical Equipment & Supplies

Classification as published by BSE.

Companies also in Medical Equipment & Supplies, in alphabetical order

All 19 companies in Medical Equipment & Supplies

Page generated from filings held to 28 Sept 2026.